Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03747276
Recruitment Status : Recruiting
First Posted : November 20, 2018
Last Update Posted : November 20, 2018
Sponsor:
Collaborator:
London Health Sciences Centre
Information provided by (Responsible Party):
Lawson Health Research Institute

Brief Summary:

The proposed study will include patients with non-haematologic cancer. Eligible patients will be invited to consent for participation in our study using standard demographic data collection forms and patient satisfaction questionnaires.

Cancer patients interested in learning more about clinical trials would be invited to go to the kiosk. A summer student approved and hired according to LHSC/Lawson criteria will be available from 0900-1630 daily for general assistance. If the student is overwhelmed by questions or numbers of patients, the Research Navigator or designate would be called to assist.

An information kiosk will be placed at the patient library on the ground floor of the LRCP. This kiosk will be outfitted with a computer and signage briefly outlining the title and purpose of the kiosk. Cancer patients interested in learning more about clinical trials would be invited to participate in our study by signing a consent form allowing the Research Navigator to contact them if they expressed interest in knowing more about a clinical trial.


Condition or disease Intervention/treatment Phase
Malignant Neoplasm Other: Clinical Trial Kiosk Not Applicable

Show Show detailed description

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 560 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Can Electronic Information Kiosks Enhance Patient Accrual for Cancer Clinical Trials? A Pilot and Feasibility Study
Actual Study Start Date : July 19, 2018
Actual Primary Completion Date : September 18, 2018
Estimated Study Completion Date : November 18, 2018

Arm Intervention/treatment
Clinical Trial Kiosk Other: Clinical Trial Kiosk
Kiosk will consist of a patient facilitator and a computer with access to general information about clinical trials and information specific to active clinical trials at the facility. Patients will be made aware of the kiosk via a large banner visible in the clinic above the kiosk.




Primary Outcome Measures :
  1. Change in accrual rate [ Time Frame: 4 months (A two month rate of accrual (May-June, 2018) will be determined before opening the kiosk. A second two month accrual period (August-September) will be used to assess the change in trial accrual. ]
    Our primary objective is to quantify the clinical trial accrual rates in a subset of trials that are selected as priority trials and are open both two months before and three months after implementation of the clinical trial information kiosk. Accrual rates before and after implementation will be compared.


Secondary Outcome Measures :
  1. Proportion of patients requesting research navigator contact [ Time Frame: 3 months ]
    1. To determine the proportion of patients who accessed the kiosk provided information so that they could be contacted by the Research Navigator.

  2. Proportion of patients contacted eligible for clinical trial [ Time Frame: 3 months ]
    2. To determine what proportion of patients who were contacted the research navigator were eligible to participate in a clinical trial.

  3. Proportion of eligible patients participating in clinical trial [ Time Frame: 5 months ]
    To determine what proportion of patients eligible for a clinical trial actually participated.

  4. Satisfaction with kiosk [ Time Frame: 2 months ]
    To evaluate patient satisfaction with the clinical trial information kiosk using a Likert scale.

  5. Proportion of patients accessing kiosk [ Time Frame: 2 months ]
    To determine the number of individuals who interacted with the information kiosk compared to total number of cancer patients seen in clinic when the kiosk is open.


Other Outcome Measures:
  1. Demographics [ Time Frame: 2 months ]
    Demographic correlations of patients seeking additional information. This will include age, sex, urban/rural status obtained from electronic health records. Patients will also be asked to voluntarily provide information on income, occupational status and whether they had previously been approached about a cancer clinical trial.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult patients diagnosed with a solid tumour cancer (including breast, central nervous system, gynecologic, gastrointestinal, genitourinary, head and neck, liver, melanoma, neuroendocrine, sarcoma, thoracic, thyroid).
  • Patients able to provide independent informed consent.

Exclusion Criteria:

  • Patients less than 18 years of age
  • Patients diagnosed with haematologic malignancy unless there is a co-existing solid tumour cancer
  • Inability to provide informed consent
  • Inability to read and comprehend written English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03747276


Contacts
Layout table for location contacts
Contact: Ted Vandenberg, MD 519-685-8500 ext 58640 ted.vandenberg@lhsc.on.ca

Locations
Layout table for location information
Canada, Ontario
London Health Sciences Centre Recruiting
London, Ontario, Canada, N6A 4G5
Contact: Ted Vandenberg, MD    519-685-8500 ext 58640    ted.vandenberg@lhsc.on.ca   
Sponsors and Collaborators
Lawson Health Research Institute
London Health Sciences Centre

Layout table for additonal information
Responsible Party: Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT03747276    
Other Study ID Numbers: Information Kiosk
First Posted: November 20, 2018    Key Record Dates
Last Update Posted: November 20, 2018
Last Verified: November 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: Present at meetings and publish in peer reviewed journal
Supporting Materials: Study Protocol
Time Frame: One year

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Lawson Health Research Institute:
clinical trial
accrual
Additional relevant MeSH terms:
Layout table for MeSH terms
Neoplasms